Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220020628 220013883 0 61 Curative (C) 2016-11-25 2017-01-17 AML18 PILOT TRIAL 01 null 220026988 PILOT TRIAL
220020629 220007056 1.87 null Disease modification (D) 2015-03-22 2015-03-30 Dasatinib 02 N 220027014 DASATINIB
220020630 220007059 1.76 null Curative (C) 2019-01-18 2019-02-18 Alemtuz+Fludara+Melphalan RIC MUD N N 220027025 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220020631 220007065 null 66.6 Curative (C) 2018-03-28 2018-03-28 AML 18 TRIAL 1 null 220027042 AML18 TRIAL
220020632 220007068 1.68 103 Palliative (P) 2015-01-19 2015-03-14 AML 18 TRIAL 1 N 220027059 AML18 TRIAL
220020634 220007077 0 82.2 Disease modification (D) 2017-03-27 2018-04-02 Dasatinib N N 220027135 DASATINIB
220020635 220007080 0 78.1 Curative (C) 2017-02-09 2017-02-14 ALEMTUZUMAB + FLUDARABINE + MELPHALAN 2 null 220027145 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220020636 220007089 null 65.4 Disease modification (D) 2016-10-27 2016-11-03 AML 18 Pilot Trial 1 N 220027179 PILOT TRIAL
220020637 220007099 1.61 65.7 Curative (C) 2016-08-24 2017-08-13 Rituximab N N 220027227 RITUXIMAB
220020638 220007100 1.75 74.3 Curative (C) 2018-05-22 2018-05-24 ALEMTUZUMAB + FLUDARABINE + MELPHALAN 2 null 220027231 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220020639 220007113 1.67 90.4 null 2016-09-29 2016-10-20 Alemtuz+Fludara+Melphalan RIC MUD N N 220027295 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220020640 220007120 1.67 70 Curative (C) 2015-02-27 2015-03-03 AML 18 TRIAL 1 N 220027314 AML18 TRIAL
220020641 220007140 1.65 null Curative (C) 2017-10-22 2017-10-22 Dasatinib N null 220027407 DASATINIB
220020642 220007149 1.62 54.7 Curative (C) 2017-01-18 2017-01-19 Alemtuz+Fludara+Melphalan RIC MUD N N 220027456 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220020643 220017590 1.76 77.3 Disease modification (D) 2016-11-12 2016-11-13 Rituximab N N 220027491 RITUXIMAB
220020644 220017590 1.71 44.2 Curative (C) 2016-09-27 2016-10-14 Alemtuz+Fludara+Melphalan RIC MUD N null 220027491 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220020645 220013949 1.76 95.5 Curative (C) 2014-01-14 2014-02-13 Alemtuz+Fludara+Melphalan RIC MUD N null 220027516 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220020646 220007164 0 null null 2015-11-14 2016-09-12 Dasatinib null N 220027518 DASATINIB
220020647 220007167 166.9 127 Curative (C) 2015-05-20 2015-05-20 Alemtuz+Fludara+Melphalan RIC MUD N N 220027534 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220020648 220013953 1.32 65.8 Palliative (P) 2014-02-14 2014-02-14 Dasatinib 2 N 220027551 DASATINIB
220020649 220007175 1.63 64 Curative (C) 2016-06-08 2016-07-18 Alemtuz+Fludara+Melphalan RIC MUD N N 220027553 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220020650 220013956 1.49 111.5 Curative (C) 2013-11-13 2014-09-07 Dasatinib N N 220027583 DASATINIB
220020651 220007182 1.7 null null 2014-04-17 2014-04-23 Alemtuz+Fludara+Melphalan RIC MUD N N 220027594 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220020652 220007197 1.75 66 Curative (C) 2015-05-24 2015-05-31 AML 18 TRIAL N N 220027658 AML18 TRIAL
220020653 220007201 1.67 67 Disease modification (D) 2014-03-22 2015-01-04 Dasatinib 2 N 220027659 DASATINIB
220020654 220007205 1.64 80.5 Disease modification (D) null 2015-11-08 AML 18 TRIAL N N 220027665 AML18 TRIAL
220020655 220019647 null 54.7 Curative (C) 2015-01-14 2015-01-21 Alemtuz+Fludara+Melphalan RIC MUD N N 220027691 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220020656 220007217 1.7 86 Curative (C) 2016-04-03 2016-04-07 AML 18 TRIAL Y N 220027703 AML18 TRIAL
220020657 220007231 1.85 116.8 Curative (C) 2016-10-14 2017-01-18 AML 18 TRIAL null N 220027754 AML18 TRIAL
220020658 220007234 1.68 82 Curative (C) 2013-11-08 2013-11-08 Dasatinib 02 N 220027773 DASATINIB
220020659 220007241 1.62 90.1 Curative (C) 2013-06-30 2013-07-09 ALEMTUZUMAB + FLUDARABINE + MELPHALAN N N 220027806 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220020660 220007248 1.54 84.2 Curative (C) 2017-06-16 2017-08-05 Dasatinib 2 N 220027816 DASATINIB
220020661 220007258 1.6 44.2 Curative (C) 2017-12-19 2017-12-19 Alemtuz+Fludara+Melphalan RIC MUD N N 220027861 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220020662 220007266 1.8 86 Curative (C) 2015-05-29 2015-06-02 AML 18 TRIAL Y N 220027906 AML18 TRIAL
220020663 220007269 1.68 50.4 Curative (C) 2017-10-27 2017-10-27 Alemtuz+Fludara+Melphalan RIC MUD null Y 220027908 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220020664 220017625 0 63 Disease modification (D) 2016-04-02 2016-05-09 AML 18 Pilot Trial Y null 220027940 PILOT TRIAL
220020665 220020843 null 94.2 Curative (C) 2017-12-01 2017-12-01 Rituximab 2 N 220027944 RITUXIMAB
220020666 220007282 null 61.8 Palliative (P) 2015-05-15 2015-07-08 AML 18 TRIAL Y N 220027982 AML18 TRIAL
220020667 220007297 1.73 77.7 Disease modification (D) 2017-01-26 2017-02-05 Alemtuz+Fludara+Melphalan RIC MUD N N 220028118 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220020668 220007298 1.73 90 Curative (C) 2016-10-23 2016-10-23 Rituximab (Maintenance) N N 220028118 RITUXIMAB
220020669 220007300 1.79 73.2 Curative (C) 2013-05-17 2013-08-15 AML 18 TRIAL N N 220028136 AML18 TRIAL
220020670 220007304 1.85 89.2 Disease modification (D) 2016-12-21 2017-04-14 Dasatinib N N 220028139 DASATINIB
220020671 220014023 1.67 73 Curative (C) 2014-10-22 2014-10-22 ALEMTUZUMAB + FLUDARABINE + MELPHALAN N N 220028151 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220020672 220007312 1.76 80.1 Disease modification (D) 2013-11-12 2013-11-15 Rituximab N N 220028170 RITUXIMAB
220020674 220021508 1.58 64.6 null 2015-02-26 2015-05-07 AML 18 TRIAL N N 220028201 AML18 TRIAL
220020675 220022207 1.75 89.5 Curative (C) 2016-03-08 2016-03-20 Alemtuz+Fludara+Melphalan RIC MUD N N 220028203 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220020676 220007322 0 73.7 Curative (C) 2017-10-10 2017-10-25 Alemtuz+Fludara+Melphalan RIC MUD 2 N 220028206 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220020677 220007325 1.8 77 Adjuvant (A) 2018-08-16 2018-08-16 Dasatinib N N 220028231 DASATINIB
220020678 220014038 1.82 84.9 Curative (C) 2013-08-22 2013-09-10 Rituximab (Maintenance) N N 220028246 RITUXIMAB
220020679 220007338 1.75 64.6 Curative (C) null 2018-05-08 AML 18 Pilot Trial Y N 220028292 PILOT TRIAL